查看購物車
  • English
封面
市場調查報告書
商品編碼
1905406

日本流感診斷市場報告（按產品、檢測類型、流感類型、最終用戶和地區分類，2026-2034年）

Japan Influenza Diagnostics Market Report by Product, Test Type, Type of Flu, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2025年，日本流感診斷市場規模達6,660萬美元。展望未來， IMARC Group預計到2034年，該市場規模將達到1.061億美元，2026年至2034年間的複合年成長率（CAGR）為5.31%。推動市場成長的因素有很多，包括疫苗接種活動的擴大、即時檢測的便利性、流感病毒研究的深入以及公共衛生舉措提高公眾意識等。

本報告解答的關鍵問題：

  • 日本流感診斷市場目前表現如何？未來幾年又將如何發展？
  • 新冠疫情對日本流感診斷市場產生了哪些影響？
  • 日本流感診斷市場依產品分類的組成是怎樣的？
  • 日本流感診斷市場依檢測類型分類的組成是怎樣的？
  • 日本流感診斷市場以流感類型分類的組成是怎樣的？
  • 日本流感診斷市場依最終用戶分類的組成是怎樣的？
  • 日本流感診斷市場價值鏈的各個階段有哪些？
  • 日本流感診斷的關鍵促進因素和挑戰是什麼？
  • 日本流感診斷市場的結構是怎麼樣的？主要參與者有哪些？
  • 日本流感診斷市場的競爭程度如何？

目錄

第1章：序言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 數據來源
  • 市場估算
  • 預測方法

第3章：執行概要

第4章：日本流感診斷市場－簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭情報

第5章：日本流感診斷市場概況

  • 歷史及當前市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章：日本流感診斷市場－依產品細分

  • 測試盒和試劑
  • 儀器
  • 其他

第7章：日本流感診斷市場－依檢測類型分類

  • 分子診斷測試
  • 傳統診斷測試

第8章：日本流感診斷市場－依流感類型分類

  • 甲型流感
  • 乙型流感
  • 丙型流感

第9章：日本流感診斷市場－以最終用戶分類

  • 醫院
  • 診斷實驗室
  • 其他

第10章：日本流感診斷市場－按地區分類

  • 關東地區
  • 關西/近畿地區
  • 中部/中部地區
  • 九州·沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第11章：日本流感診斷市場－競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳制勝策略
  • 競爭格局分析
  • 公司評估象限

第12章：關鍵參與者簡介

第13章：日本流感診斷市場－產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第14章：附錄

簡介目錄
Product Code: SR112026A19551

Japan influenza diagnostics market size reached USD 66.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 106.1 Million by 2034, exhibiting a growth rate (CAGR) of 5.31% during 2026-2034. The market is being driven by several factors, including the expansion of vaccination campaigns, the convenience offered by point-of-care testing, intensified research into influenza viruses, and increased awareness through public health initiatives.

Influenza, commonly referred to as the flu, is a viral infection that primarily targets the respiratory system, affecting areas such as the nose, throat, and lungs. The realm of influenza diagnostics encompasses a variety of immunoassay tests designed to detect the presence of nucleoprotein antigens from influenza A and B viruses in respiratory samples. Among the available diagnostic methods are rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serological tests, and rapid molecular assays. These diagnostic options are relied upon by healthcare professionals to promptly identify and categorize influenza strains, facilitating effective treatment decisions and enabling efficient public health management.

Japan Influenza Diagnostics Market Trends:

The influenza diagnostics market in Japan is witnessing substantial growth, driven by a combination of factors. Foremost among these is the increasing incidence of flu outbreaks, which necessitates effective diagnostic solutions. Apart from this, the growing concerns regarding the potential for pandemics have spurred investments in diagnostic capabilities, making a significant contribution to market expansion. Furthermore, continuous technological advancements in the field are enhancing the accuracy and speed of diagnostic tests, positively impacting the market's growth trajectory. Besides this, public awareness campaigns focused on the importance of timely testing have encouraged more individuals to seek diagnostic services, further catalyzing market demand. Japan's rising healthcare spending supports the adoption of advanced diagnostic methods, contributing to market growth. Additionally, elderly individuals, who are more vulnerable to severe cases of the flu, are driving increased demand for diagnostic services. The growth of urban populations in Japan has led to higher infection rates, underscoring the need for robust diagnostic solutions. Frequent travel within the country and internationally has accelerated the spread of the flu, further highlighting the importance of efficient diagnostics. These factors will collectively create numerous opportunities for the influenza diagnostics market in Japan over the forecasted period.

Japan Influenza Diagnostics Market Segmentation:

Product Insights:

  • Test Kit and Reagents
  • Instruments
  • Others

Test Type Insights:

  • Molecular Diagnostic Tests
    • Polymerase Chain Reaction
    • Isothermal Nucleic Acid Amplification Tests
    • Others
  • Traditional Diagnostic Tests
    • Rapid Influenza Diagnostic Tests
    • Viral Culture Tests
    • Direct Fluorescent Antibody Test
    • Serological Tests

Type of Flu Insights:

  • Type A Flu
  • Type B Flu
  • Type C Flu

End User Insights:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan influenza diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan influenza diagnostics market?
  • What is the breakup of the Japan influenza diagnostics market on the basis of product?
  • What is the breakup of the Japan influenza diagnostics market on the basis of test type?
  • What is the breakup of the Japan influenza diagnostics market on the basis of type of flu?
  • What is the breakup of the Japan influenza diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the Japan influenza diagnostics market?
  • What are the key driving factors and challenges in the Japan influenza diagnostics?
  • What is the structure of the Japan influenza diagnostics market and who are the key players?
  • What is the degree of competition in the Japan influenza diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Influenza Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Influenza Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Influenza Diagnostics Market - Breakup by Product

  • 6.1 Test Kit and Reagents
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Instruments
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Others
    • 6.3.1 Historical and Current Market Trends (2020-2025)
    • 6.3.2 Market Forecast (2026-2034)

7 Japan Influenza Diagnostics Market - Breakup by Test Type

  • 7.1 Molecular Diagnostic Tests
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Segmentation
      • 7.1.3.1 Polymerase Chain Reaction
      • 7.1.3.2 Isothermal Nucleic Acid Amplification Tests
      • 7.1.3.3 Others
    • 7.1.4 Market Forecast (2026-2034)
  • 7.2 Traditional Diagnostic Tests
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Rapid Influenza Diagnostic Tests
      • 7.2.3.2 Viral Culture Tests
      • 7.2.3.3 Direct Fluorescent Antibody Test
      • 7.2.3.4 Serological Tests
    • 7.2.4 Market Forecast (2026-2034)

8 Japan Influenza Diagnostics Market - Breakup by Type of Flu

  • 8.1 Type A Flu
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Type B Flu
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Type C Flu
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)

9 Japan Influenza Diagnostics Market - Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Others
    • 9.3.1 Historical and Current Market Trends (2020-2025)
    • 9.3.2 Market Forecast (2026-2034)

10 Japan Influenza Diagnostics Market - Breakup by Region

  • 10.1 Kanto Region
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Breakup by Product
    • 10.1.4 Market Breakup by Test Type
    • 10.1.5 Market Breakup by Type of Flu
    • 10.1.6 Market Breakup by End User
    • 10.1.7 Key Players
    • 10.1.8 Market Forecast (2026-2034)
  • 10.2 Kansai/Kinki Region
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Breakup by Product
    • 10.2.4 Market Breakup by Test Type
    • 10.2.5 Market Breakup by Type of Flu
    • 10.2.6 Market Breakup by End User
    • 10.2.7 Key Players
    • 10.2.8 Market Forecast (2026-2034)
  • 10.3 Central/ Chubu Region
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Breakup by Product
    • 10.3.4 Market Breakup by Test Type
    • 10.3.5 Market Breakup by Type of Flu
    • 10.3.6 Market Breakup by End User
    • 10.3.7 Key Players
    • 10.3.8 Market Forecast (2026-2034)
  • 10.4 Kyushu-Okinawa Region
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Breakup by Product
    • 10.4.4 Market Breakup by Test Type
    • 10.4.5 Market Breakup by Type of Flu
    • 10.4.6 Market Breakup by End User
    • 10.4.7 Key Players
    • 10.4.8 Market Forecast (2026-2034)
  • 10.5 Tohoku Region
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Breakup by Product
    • 10.5.4 Market Breakup by Test Type
    • 10.5.5 Market Breakup by Type of Flu
    • 10.5.6 Market Breakup by End User
    • 10.5.7 Key Players
    • 10.5.8 Market Forecast (2026-2034)
  • 10.6 Chugoku Region
    • 10.6.1 Overview
    • 10.6.2 Historical and Current Market Trends (2020-2025)
    • 10.6.3 Market Breakup by Product
    • 10.6.4 Market Breakup by Test Type
    • 10.6.5 Market Breakup by Type of Flu
    • 10.6.6 Market Breakup by End User
    • 10.6.7 Key Players
    • 10.6.8 Market Forecast (2026-2034)
  • 10.7 Hokkaido Region
    • 10.7.1 Overview
    • 10.7.2 Historical and Current Market Trends (2020-2025)
    • 10.7.3 Market Breakup by Product
    • 10.7.4 Market Breakup by Test Type
    • 10.7.5 Market Breakup by Type of Flu
    • 10.7.6 Market Breakup by End User
    • 10.7.7 Key Players
    • 10.7.8 Market Forecast (2026-2034)
  • 10.8 Shikoku Region
    • 10.8.1 Overview
    • 10.8.2 Historical and Current Market Trends (2020-2025)
    • 10.8.3 Market Breakup by Product
    • 10.8.4 Market Breakup by Test Type
    • 10.8.5 Market Breakup by Type of Flu
    • 10.8.6 Market Breakup by End User
    • 10.8.7 Key Players
    • 10.8.8 Market Forecast (2026-2034)

11 Japan Influenza Diagnostics Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Product Portfolio
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Influenza Diagnostics Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix